Guggenheim Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-2,643
| Closed | -$16K | – | 3082 |
|
|
2016
Q3 | $16K | Buy |
2,643
+1,460
| +123% | +$8.84K | ﹤0.01% | 2843 |
|
|
2016
Q2 | $5K | Sell |
1,183
-96
| -8% | -$406 | ﹤0.01% | 2867 |
|
|
2016
Q1 | $13K | Sell |
1,279
-923
| -42% | -$9.38K | ﹤0.01% | 2856 |
|
|
2015
Q4 | $65K | Buy |
2,202
+745
| +51% | +$22K | ﹤0.01% | 2880 |
|
|
2015
Q3 | $46K | Buy |
1,457
+436
| +43% | +$13.8K | ﹤0.01% | 2858 |
|
|
2015
Q2 | $60K | Buy |
+1,021
| New | +$60K | ﹤0.01% | 2946 |
|
|
2014
Q3 | – | Sell |
-1,235
| Closed | -$111K | – | 3151 |
|
|
2014
Q2 | $111K | Sell |
1,235
-410
| -25% | -$36.9K | ﹤0.01% | 2947 |
|
|
2014
Q1 | $88K | Buy |
1,645
+265
| +19% | +$14.2K | ﹤0.01% | 2993 |
|
|
2013
Q4 | $35K | Buy |
+1,380
| New | +$35K | ﹤0.01% | 3025 |
|